TherapeuticsMD, Inc. Income Statement

Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.24M2.09M3.82M8.78M15.03M20.14M19.36M16.78M16.10M49.65M64.87M2.57M69.96M1.30M1.76M
Cost of Revenue 0.56M0.95M1.35M1.96M3.67M4.51M4.19M2.64M2.74M114.23M117.05M1.40M1.40M
Gross Profit 0.69M1.14M2.47M6.82M11.35M15.64M15.17M14.14M13.36M43.31M48.90M1.17M68.57M1.30M
Operating items
Amortization - Intangibles 0.03M1.60M0.02M0.01M0.01M
Depreciation & Amortization - Total 0.03M0.03M0.60M0.10M
Research & Development 0.07M0.11M4.49M13.55M43.22M72.04M53.94M33.85M27.30M19.79M10.43M7.09M
Selling, General & Administrative 3.46M6.41M14.07M19.01M22.12M28.72M51.35M57.70M115.99M60.49M76.95M80.75M56.71M8.90M4.74M
Restructuring Costs 9.47M
Other Operating Expenses 0.02M0.03M0.03M0.06M0.05M0.06M0.13M0.21M0.29M114.23M117.05M-7.09M0.59M0.82M1.78M
Operating Expenses 3.55M6.57M18.62M32.62M65.40M100.83M105.42M91.77M143.58M194.52M204.44M80.75M67.38M9.82M6.52M
Operating Income -2.87M-5.43M-16.15M-25.81M-54.04M-85.19M-90.25M-77.63M-130.22M-151.21M-155.54M-79.58M1.19M-8.52M-4.76M
EBIT -2.87M-5.43M-16.15M-25.81M-54.04M-85.19M-90.25M-77.63M-130.22M-151.21M-155.54M-79.58M1.19M-8.52M-4.76M
Non-operating items
Interest & Investment Income 0.03M0.04M0.02M0.01M
Other Non Operating Income -7.39M-10.31M0.03M0.05M0.10M0.37M0.70M2.28M-10.06M0.60M0.27M-0.12M
Non Operating Income -7.49M-18.97M-2.61M-0.18M0.11M0.38M0.70M-2.40M-24.94M-27.98M0.27M-0.12M0.78M2.42M
Net income details
EBT -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-79.31M1.07M-7.74M-2.34M
Tax Provisions -0.04M-0.03M
Profit After Tax -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-172.41M112.00M-10.28M-2.31M
Income from Continuing Operations -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-79.31M1.07M-7.70M-2.31M
Consolidated Net Income -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-93.11M110.92M-2.58M0.13M
Income towards Parent Company -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-93.11M110.92M-2.58M0.13M
Net Income towards Common Stockholders -2.87M-12.91M-35.12M-28.42M-54.22M-85.08M-89.88M-76.93M-132.62M-176.15M-183.52M-93.11M110.92M-2.58M0.13M
Additional items
EPS (Basic) -0.07-0.21-0.38-0.22-0.36-0.49-0.46-0.37-0.59-0.72-0.67-21.6612.41-0.99-0.20
EPS (Weighted Average and Diluted) -21.6611.96-0.99-0.20
Shares Outstanding (Weighted Average) 1.69M2.00M2.90M3.43M3.56M3.93M4.33M4.82M5.42M5.46M8.50M9.47M10.58M11.53M
Shares Outstanding (Diluted Average) 9.37M0.01M0.01M
EBITDA -2.87M-5.40M-16.12M-25.81M-54.04M-85.19M-90.25M-77.63M-130.22M-176.15M-183.52M-172.41M112.00M-10.28M-4.76M
Interest Expenses 0.06M1.91M1.17M1.17M4.68M17.38M28.58M32.92M
Tax Rate 0.56%1.32%